Shelley Penna
Family · Haverhill, MANPI 1831109602
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.4% of the total across 299 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Johnson & Johnson at 24.1% of the total. Among family clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 299 payments — averaging $23.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- AbbVie$1K
- UCB, Inc.$929
- Lilly USA, LLC$880
- Pfizer$404
- E.r. Squibb & Sons, L.L.C.$339
- plus $2K from 16 others
What the payments were for
- Food & beverage$6,36792%
- Education$5248%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 61 | $1,658 |
| AbbVie | 54 | $1,074 |
| UCB, Inc. | 32 | $929 |
| Lilly USA, LLC | 43 | $880 |
| Pfizer | 15 | $404 |
| E.r. Squibb & Sons, L.L.C. | 15 | $339 |
| Arcutis Biotherapeutics, Inc. | 26 | $286 |
| LEO Pharma Inc. | 8 | $247 |
| Sun Pharmaceutical Industries Inc. | 7 | $219 |
| Sanofi | 5 | $193 |
| Dermavant Sciences, Inc. | 7 | $169 |
| Incyte Corporation | 5 | $105 |
| Galderma Laboratories, L.p. | 6 | $89 |
| Regeneron Healthcare Solutions, Inc. | 3 | $52 |
| Organon | 4 | $49 |
| Novartis | 2 | $45 |
| Amgen | 1 | $34 |
| Boehringer Ingelheim | 1 | $33 |
| Bristol Myers Squibb | 1 | $26 |
| Biofrontera Inc. | 1 | $21 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $21 |
| Botanix SB Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,891 in reported general payments places this provider in the 95th percentile of 2,320 family providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 11 | $72,844 |
| Dupixent SyringeDupilumab | 11 | $41,162 |
| Clobetasol Propionate | 32 | $2,252 |
| Fluorouracil | 23 | $1,146 |
| Doxycycline Hyclate | 26 | $745 |
| Fluocinonide | 28 | $742 |
| Ketoconazole | 22 | $394 |
| Minoxidil | 26 | $294 |
| Triamcinolone Acetonide | 24 | $233 |
Paid to pharmacies, not to this prescriber.
Other family in Haverhill
- Paul GouldLakeville$343K
- Brittany MurrayBoston$141K
- Jennifer FlemingLawrence$80K
- Naomi AmudalaBoston$79K
- Geoffrey WhitleyCharlestown$66K
- Katherine O'BrienWinthrop$58K
- Kristy SmithActon$57K
- Leslie StefanowiczDartmouth$56K
- Marissa CasilloFoxborough$31K
- Rochelle NazarianDanvers$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.